Drug Profile


Alternative Names: Ebastine/pseudoephedrine hydrochloride; EBPS; Pseudoephedrine hydrochloride/ebastine; Pseudoephedrine/ebastine; Rino-Ebastel

Latest Information Update: 21 Mar 2014

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Almirall S.A.
  • Class Antiallergics; Biphenyl compounds; Butyrophenones; Decongestants; Piperidines; Propanolamines; Small molecules
  • Mechanism of Action Alpha adrenergic receptor agonists; Histamine H1 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Allergic rhinitis

Most Recent Events

  • 31 Dec 2012 Launched for Allergic rhinitis in Spain (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top